Company Profile
Regenlab
Company Overview
Regen Lab is a leading innovator of medical device in the field of products intended for autologous regenerative medicine, based on an extemporaneous preparation of Platelet-Rich Plasma (PRP, autologous thrombin…) from the patient’s blood, cell therapy (in particular extract MSCs from bone marrow) and combined therapy (PRP combined with hyaluronic acid).
To date, Regen Lab’s patented technologies are available in over 160 countries worldwide, and have been used to treat over 2 million patients in various therapeutic areas (musculoskeletal, dermal, wound care and intimacy)leading to the publication of over 120 research projects.
Since 2003, RegenLab® has been committed to the development of a unique expertise in the design and manufacture of high-quality medical devices, intended for the preparation of autologous cellular therapies prepared from the patient’s own blood, especially platelet-rich plasma.
In 2009, a Good Manufacturing Practice (GMP) facility was completed in Mont-sur-Lausanne, Switzerland allowing RegenLab® to increase access to autologous cellular therapies around the world.
The majority of our medical devices are now Developed and Manufactured in the USA, in Brooklyn, as of November 2021.